June 24, 2018 06:38 PM EDT
Financing
Startups

UK start­up NodThera banks a $40M round with plans to con­quer a close­ly-stud­ied in­flam­ma­to­ry tar­get

John Carroll

Editor & Founder

A start­up in Cam­bridge, UK called NodThera has banked a $40 mil­lion A round to dig deep­er in­to de­vel­op­ing small mol­e­cules tar­get­ing NL­RP3, a rather …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times